The <a target="_blank" href="https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812">nuclear medicine/ radiopharmaceuticals market size</a> was reached at USD 7.53 billion in 2022 and is expected to expand at a CAGR of 19.5% from 2022 to 2030, reaching USD 29.35 billion by 2030. This growth underscores substantial opportunities in this rapidly expanding, high-volume industry. The report offers a comprehensive analysis of the overall market conditions, trends, regional insights, opportunities, key players, and market segmentation, delivering crucial information for business success.

The [*nuclear medicine/ radiopharmaceuticals market size*](https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812) was reached at **USD 7.53 billion** in **2022** and is expected to expand at a CAGR of **19.5%** from **2022** to **2030**, reaching **USD 29.35 billion** by **2030**. This growth underscores substantial opportunities in this rapidly expanding, high-volume industry. The report offers a comprehensive analysis of the overall market conditions, trends, regional insights, opportunities, key players, and market segmentation, delivering crucial information for business success.

Nuclear Medicine/Radiopharmaceuticals Market: CAGR of 19.5% Growth by 2030